Related Experiment Video
Updated: May 6, 2026

In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
Published on: January 22, 2020
Phosphorylation of FOXP3 by LCK downregulates MMP9 expression and represses cell invasion
Kumiko Nakahira1, Akihiro Morita, Nam-Soon Kim
1Department of Developmental Medicine, Research Institute, Osaka Medical Center for Maternal and Child Health, Izumi, Osaka, Japan.
Abstract:
Forkhead Box P3 (FOXP3) is a member of the forkhead/winged helix family of the transcription factors and plays an important role not only as a master gene in T-regulatory cells, but also as a tumor suppressor. In this study, we identified lymphocyte-specific protein tyrosine kinase (LCK), which correlates with cancer malignancy, as a binding partner of FOXP3. FOXP3 downregulated LCK-induced MMP9, SKP2, and VEGF-A expression. We observed that LCK phosphorylated Tyr-342 of FOXP3 by immunoprecipitation and in vitro kinase assay, and the replacement of Tyr-342 with phenylalanine (Y342F) abolished the ability to suppress MMP9 expression. Although FOXP3 decreased the invasive ability induced by LCK in MCF-7 cells, Y342F mutation in FOXP3 diminished this suppressive effect. Thus we demonstrate for the first time that LCK upregulates FOXP3 by tyrosine phosphorylation, resulting in decreased MMP9, SKP2, and VEGF-A expression, and suppressed cellular invasion. We consider that further clarification of transcriptional mechanism of FOXP3 may facilitate the development of novel therapeutic approaches to suppress cancer malignancy.
Insights
Lymphocyte-specific protein tyrosine kinase (LCK) upregulates Forkhead Box P3 (FOXP3) via tyrosine phosphorylation. This interaction suppresses cancer malignancy by reducing MMP9, SKP2, and VEGF-A expression and inhibiting cellular invasion.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- Forkhead Box P3 (FOXP3) is a transcription factor crucial for T-regulatory cells and acts as a tumor suppressor.
- Cancer malignancy is associated with lymphocyte-specific protein tyrosine kinase (LCK).
- The interaction between FOXP3 and LCK in cancer is not well understood.
Purpose of the Study:
- To investigate the relationship between FOXP3 and LCK in the context of cancer malignancy.
- To elucidate the mechanism by which LCK affects FOXP3 activity and downstream targets.
- To determine the role of LCK-mediated phosphorylation of FOXP3 in regulating cancer-associated genes and invasion.
Main Methods:
- Identification of LCK as a binding partner of FOXP3.
- Immunoprecipitation and in vitro kinase assays to confirm LCK phosphorylation of FOXP3 at Tyr-342.
- Functional assays using wild-type FOXP3 and a Y342F mutant to assess effects on MMP9, SKP2, VEGF-A expression, and cellular invasion in MCF-7 cells.
Main Results:
- LCK was identified as a binding partner of FOXP3.
- LCK phosphorylates FOXP3 at Tyr-342, which is essential for FOXP3's ability to suppress MMP9 expression and cellular invasion.
- LCK-induced upregulation of FOXP3 leads to decreased expression of MMP9, SKP2, and VEGF-A, and suppressed cellular invasion.
Conclusions:
- LCK upregulates FOXP3 through tyrosine phosphorylation at Tyr-342.
- This LCK-FOXP3 interaction suppresses key genes (MMP9, SKP2, VEGF-A) involved in cancer malignancy and reduces cellular invasion.
- Understanding this mechanism offers potential for novel therapeutic strategies against cancer.
More Related Videos
07:26Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
Published on: April 1, 2022
10:16SorLA and CLC:CLF-1-dependent Downregulation of CNTFRα as Demonstrated by Western Blotting, Inhibition of Lysosomal Enzymes, and Immunocytochemistry
Published on: January 6, 2017
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
The JAK-STAT Signaling Pathway
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...